Cargando…

The role of complement activation in COPD exacerbation recovery

Rise in sputum complement (C3a, C5a) levels during COPD exacerbation is associated with recovery time http://ow.ly/ZaPj303xxPf

Detalles Bibliográficos
Autores principales:	Westwood, John-Paul, Mackay, Alexander J., Donaldson, Gavin, Machin, Samuel J., Wedzicha, Jadwiga A., Scully, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2016
Materias:	Original Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152850/ https://www.ncbi.nlm.nih.gov/pubmed/28053974 http://dx.doi.org/10.1183/23120541.00027-2016

Ejemplares similares

Deprivation, winter season, and COPD exacerbations
por: Donaldson, Gavin C, et al.
Publicado: (2013)

The causes and consequences of seasonal variation in COPD exacerbations
por: Donaldson, Gavin C, et al.
Publicado: (2014)

Acute Exacerbations of COPD
por: Wedzicha, Jadwiga A.
Publicado: (2009)

Management of exacerbations of COPD
por: Seemungal, Terence, et al.
Publicado: (2003)

Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013)

Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura
por: Westwood, John-Paul, et al.
Publicado: (2014)

Is gastro-oesophageal reflux associated with COPD exacerbations?
por: Wedzicha, Jadwiga A.
Publicado: (2013)

The role of bronchodilator treatment in the prevention of exacerbations of COPD
por: Wedzicha, Jadwiga A., et al.
Publicado: (2012)

COPD exacerbations: defining their cause and prevention
por: Wedzicha, Jadwiga A, et al.
Publicado: (2007)

Effect of Interactions Between Lower Airway Bacterial and Rhinoviral Infection in Exacerbations of COPD
por: Wilkinson, Tom M.A., et al.
Publicado: (2006)

Community-based recruitment of patients with COPD into clinical research
por: Brill, Simon E, et al.
Publicado: (2014)

Acute Exacerbations of COPD
por: Wedzicha, J.A.
Publicado: (2002)

Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies
por: Wedzicha, Jadwiga A., et al.
Publicado: (2016)

Early Clinically Important Improvement (ECII) and Exacerbation Outcomes in COPD Patients
por: Kostikas, Konstantinos, et al.
Publicado: (2020)

Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
por: Mackay, Alexander J., et al.
Publicado: (2020)

Exacerbation rate, health status and mortality in COPD – a review of potential interventions
por: Seemungal, Terence AR, et al.
Publicado: (2009)

Daily activity during stability and exacerbation of chronic obstructive pulmonary disease
por: Alahmari, Ayedh D, et al.
Publicado: (2014)

25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease
por: Quint, Jennifer K, et al.
Publicado: (2012)

Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease
por: Wedzicha, Jadwiga A, et al.
Publicado: (2013)

Impact of the UK lockdown on people at risk of COPD
por: Donaldson, Gavin C., et al.
Publicado: (2021)

Strategies for improving outcomes of COPD exacerbations
por: Wilkinson, Tom, et al.
Publicado: (2006)

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)

Trends in management and outcomes of COPD patients in primary care, 2000–2009: a retrospective cohort study
por: James, Gareth D, et al.
Publicado: (2014)

Impact of a functional polymorphism in the PAR-1 gene promoter in COPD and COPD exacerbations
por: Platé, Manuela, et al.
Publicado: (2014)

Exacerbations: Etiology and Pathophysiologic Mechanisms
por: Wedzicha, Jadwiga A.
Publicado: (2002)

Misspecification of at‐risk periods and distributional assumptions in estimating COPD exacerbation rates: The resultant bias in treatment effect estimation
por: Law, M., et al.
Publicado: (2016)

Influence of weather and atmospheric pollution on physical activity in patients with COPD
por: Alahmari, Ayedh D., et al.
Publicado: (2015)

Use of long-term antibiotic treatment in COPD patients in the UK: a retrospective cohort study
por: James, Gareth Dean Russell, et al.
Publicado: (2013)

Defective monocyte-derived macrophage phagocytosis is associated with exacerbation frequency in COPD
por: Singh, R., et al.
Publicado: (2021)

MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation
por: Mercer, PF, et al.
Publicado: (2005)

Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot study
por: Hurst, John R, et al.
Publicado: (2010)

Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study
por: Dal Negro, Roberto W., et al.
Publicado: (2017)

Management of Exacerbations in Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2012)

Cognitive function and inhaler technique following recovery from exacerbations of COPD
por: Henkle, Benjamin E., et al.
Publicado: (2023)

Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2008)

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
por: Vogelmeier, Claus F, et al.
Publicado: (2018)

Acute exacerbations of chronic obstructive pulmonary disease: treatment and prevention
por: Seemungal, Terence, et al.
Publicado: (2008)

Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review
por: Hurst, John R, et al.
Publicado: (2009)

Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD
por: Donaldson, Gavin C., et al.
Publicado: (2005)

Bacteria and sputum inflammatory cell counts; a COPD cohort analysis
por: Beech, Augusta S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_18er15i076271pdestpa0as3bs